RIBOCICLIB

Clinical trials for RIBOCICLIB explained in plain language.

Never miss a new study

Get alerted when new RIBOCICLIB trials appear

Sign up with your email to follow new studies for RIBOCICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New drug may protect breast cancer patients from dangerous infection risk

Disease control Recruiting now

This study tests whether a drug called leucogen can prevent severe neutropenia (dangerously low white blood cell counts) in people with early-stage hormone receptor-positive, HER2-negative breast cancer who are taking ribociclib and hormone therapy. About 94 participants will rec…

Matched conditions: RIBOCICLIB

Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated May 15, 2026 11:53 UTC

RIBOCICLIB

Get alerted when new RIBOCICLIB trials appear

New drug may protect breast cancer patients from dangerous infection risk